Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Regeneron Pharmaceuticals
With
Sanofi
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and women with elevated cholesterol on stable doses of atorvastatin 10-40mg/day regimen
Body mass index between 18.0 and 35.0 kg/m2, inclusive
For women of childbearing potential, a negative serum pregnancy test at the screening visit and a negative urine pregnancy test on day -2 or day -1
For men and women of childbearing potential, willingness to utilize adequate contraception and not become pregnant (or have their partner\[s\] become pregnant)during the full duration of the study
Willing, committed and able to return for all the clinic visits and complete all study-related procedures
Able to read, and able to sign the informed consent form
You may not be if
History of MI, ACS, Angina, Stroke, peripheral vascular disease, or cardiac revascularization
Pregnant or breast-feeding women
Blood donation of any volume within 1 month prior to administration of study drug
Congestive heart failure
Consumption of greater than 1 quart of grapefruit juice per day
Previous exposure to any therapeutic or investigational biological agent within 30 days of screening
History of alcohol or drug abuse within one year to the screening visit
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Clareo Health | Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin
